Dizziness, a common and often elusive symptom, can be challenging for clinicians to diagnose and manage. This article aims to provide a comprehensive approach to diagnosing and treating vertigo, a specific subtype of dizziness characterized by a sensation of spinning or movement.
Vertigo is typically a manifestation of vestibular dysfunction. It is crucial to distinguish vertigo from other forms of dizziness such as presyncope, disequilibrium, and non-specific dizziness. A thorough patient history and physical examination are the cornerstones of diagnosis.
Key aspects of the history include onset, duration, triggers, associated symptoms, and any previous episodes. A targeted neurological and otological examination, along with specific tests like the Dix-Hallpike maneuver or the head impulse test, can help localize the pathology to the peripheral or central vestibular system.
While the diagnosis of vertigo is primarily clinical, adjunctive diagnostic modalities like vestibular function tests, audiometry, and neuroimaging can provide valuable information. These should be used judiciously based on clinical suspicion and to rule out serious causes like stroke or tumours.
Treatment of vertigo is multifaceted and includes symptomatic relief with medications, vestibular rehabilitation, and in some cases, surgery. The choice of treatment is guided by the underlying cause, severity of symptoms, and the patient's overall health status.
Vertigo, while common, can be daunting to diagnose and manage. A systematic approach to history taking, examination, and judicious use of diagnostic modalities can help clinicians navigate this complex condition. Tailored treatment strategies can significantly improve patient outcomes and quality of life.
1.
A new way to measure suicide risk?
2.
3D virtual staining technology enables non-invasive observation of cancer tissue
3.
Perioperative Nivolumab Boosts EFS Versus Neoadjuvant-Only Nivolumab in NSCLC
4.
I Understand Why Defense Secretary Austin Kept His Prostate Cancer Quiet.
5.
ASCO: Vepdegestrant ups survival in ER+, HER2− advanced breast cancer with ESR1 mutations
1.
Hemophilia B and Gene Therapy: A New Chapter with Etranacogene Dezaparvovec
2.
Driving Impact: Oncology Pharmaceutical Marketing Strategies in the USA
3.
7 Subtle Signs of Leukemia: How to Spot the Symptoms Early
4.
Predicting Incidental Prostate Cancer in BPH Surgery Patients
5.
How Should We Approach Solid Pseudopapillary Neoplasm of the Pancreas with Hepatic Metastases?
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
2.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
3.
Current Scenario of Cancer- Q&A Session to Close the Gap Part II
4.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
5.
Navigating the Complexities of Ph Negative ALL - Part IX
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation